22 results
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
6.5 % - Reduces Risk ... Complications Risk ... • High risk ... Presence of vascular risk ... pancreatitis), Infections
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
Jardiance) - Best risk ... mortality in high risk ... hypovolemia) • GU infections ... Canagliflozin ↑ risk ... #Summary #DM2 #
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... outcomes in high risk ... effect) • May ↑ risk ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #
Causes of Sudden Unexpected Death in Infancy (SUDI) - Differential Diagnosis Algorithm
Congenital Anomaly / Disorder:
 •
Neurologic Anomaly • Pulmonary ... Metabolic Disorders Infection ... Gastrointestinal infection ... Sudden Infant Death Syndrome ... 80% of SUDI • Risk
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk ... murmur 3/6) - Pulmonary ... Skin exam for infection ... Insulin dependent DM ... days before Pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Pulmonary fibrotic ... kidney disease • DM ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
are subcutaneous injections ... carrying only a low risk ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... Dosing #Diabetes #DM2
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
with epidemic risk ... patients are still at risk ... opportunistic #infections ... #HIVAIDS #pharmacology
Refeeding Syndrome: Pathogenesis and clinical findings

Patients at Risk of Refeeding Syndrome:
 - Little or no nutritional
Refeeding Syndrome ... Patients at Risk ... of Refeeding Syndrome ... BMI < 18.5 kg/m2 ... - CHF - Pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Pulmonary fibrotic ... kidney disease • DM ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk